A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule

Exclusion Criteria

• •Patients who have known hypersensitivity to any ingredient of the product
• •Patients who have had a recent acute myocardial infarction
• •Patients who have uncompensated heart failure
• •Patients who have conditions with a potential to increase QT interval (QT-interval prolongation or history of QT prolongation; congenital long QT syndrome; use with other drugs known to increase the QT interval; arrhythmias treated with class I and III antiarrhythmic drugs)